Transcriptomic analysis validates gene expression changes linked to Type 1 Diabetes progression and C-peptide decline

Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the destruction of insulin-producing beta cells, leading to significant long-term complications. The rate of decline in endogenous insulin secretion, often measured by C-peptide levels, varies considerably among patients after diagnosis, complicating both disease management and the development of effective treatments. Understanding the molecular drivers behind this heterogeneity is critical. Previous research identified specific gene expression changes within the first year post-diagnosis that correlated with C-peptide decline at two years, suggesting a potential for early prognostic markers. This study aimed to validate these initial findings and enhance statistical power.

Researchers conducted a validation study using transcriptomic data analysis from a follow-up INNODIA cohort of 168 individuals newly diagnosed with Type 1 diabetes. The study's primary objective was to replicate previously identified associations between longitudinal gene expression changes and disease progression. Data from this new cohort were subsequently combined with the original INNODIA cohort for an integrated analysis, significantly increasing statistical power. The team longitudinally examined gene expression alterations occurring during the first year after T1D onset, correlating these changes with the rate of disease progression, patient age, and estimated immune cell abundances using bioinformatics methods.

Analysis of the independent follow-up cohort successfully validated the previously observed longitudinal shifts in gene expression during the initial year post-diagnosis, confirming their association with disease progression. In the integrated dataset, transcriptomic analysis revealed a substantial number of genes exhibiting differential expression within the first year following disease onset. These identified gene expression patterns provide a deeper molecular insight into the early stages of Type 1 diabetes. > More rapid Type 1 diabetes progression was significantly associated with younger age at diagnosis and a relative decrease in neutrophil abundance. Furthermore, specific changes in the expression levels of several individual genes were found to be directly correlated with the rate at which the disease progressed. While the abstract does not provide specific numerical values (e.g., p-values, fold-changes, percentages), the qualitative findings strongly support the role of early transcriptomic changes as indicators of disease trajectory.